TelyRx (OTCQX:TELYF) announced it has surpassed 1 million prescriptions filled nationwide since inception, marking a key growth milestone for its digital, cash-pay pharmacy platform.
The company offers 450+ FDA-approved medications for 60+ conditions and says its infrastructure can serve over 97% of the U.S. population.
TelyRx (TSX:TELY, OTCQX:TELYF), a technology-enabled healthcare and pharmacy services company, announced its subordinate voting shares now trade on the OTCQX Best Market in the United States under symbol TELYF.
The shares will continue trading on the TSX. According to TelyRx, OTCQX trading offers U.S. investors easier access in U.S. dollars and supports goals of improved market accessibility, liquidity, and long-term shareholder value.